Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy.
纤溶酶对人类 Fas 配体 (CD95L) 在实体瘤免疫治疗中的进化调控
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-60990-0
Wamba Brice E N, Mondal Tanmoy, Freenor V Francis, Shaheed Mehr, Pang Oliver, Bedinger Daniel, Legembre Patrick, Devel Laurent, Bhatnagar Sanchita, Leiserowitz Gary Scott, Tushir-Singh Jogender
